Company Profiles

driven by the PitchBook Platform

Longevity Biotech

Description

Provider of a class of therapeutics via an artificial protein technology. The company provides hybridtides, targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymes and tunable to very stable molecular structures.

2010

Founded

PRIVATE

Status

Grant

Latest Deal Type

$350k

Latest Deal Amount

$170k

Total Amount Raised

1

Investors

Description

Provider of a class of therapeutics via an artificial protein technology. The company provides hybridtides, targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymes and tunable to very stable molecular structures.

Website:

www.longevitybiotech.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

3624 Market Street Suite 300 Philadelphia, PA 19104United States +1 (215) 689-1042
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Longevity Biotech's full profile, request a free trial.

Longevity Biotech Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Longevity Biotech Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Breakout LabsAccelerator/IncubatorMinority000 0000000 0000
Breakout Labs Accelerator/Incubator

Longevity Biotech Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Scott Shandler Ph.DChief Executive Officer, President, Director & Co-Founder
Uma Sinha Ph.DExecutive Vice President, Preclinical Development
Samuel Gellman Ph.DCo-Founder & Head, Peptide Chemistry
Scott Shandler Ph.D Chief Executive Officer, President, Director & Co-Founder
Uma Sinha Ph.D Executive Vice President, Preclinical Development
Samuel Gellman Ph.D Co-Founder & Head, Peptide Chemistry
Request full access to PitchBook